124 related articles for article (PubMed ID: 24438718)
1. Development of a symptom index for patients with primary brain tumors.
Lai JS; Jensen SE; Beaumont JL; Abernethy AP; Jacobsen PB; Syrjala K; Raizer JJ; Cella D
Value Health; 2014; 17(1):62-9. PubMed ID: 24438718
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of treatment- and disease-related symptoms in advanced head and neck cancer: validation of the national comprehensive cancer network-functional assessment of cancer therapy-head and neck cancer symptom index-22 (NFHNSI-22).
Pearman TP; Beaumont JL; Paul D; Abernethy AP; Jacobsen PB; Syrjala KL; Von Roenn J; Cella D
J Pain Symptom Manage; 2013 Jul; 46(1):113-20. PubMed ID: 23017622
[TBL] [Abstract][Full Text] [Related]
3. Priority symptoms in advanced breast cancer: development and initial validation of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index (NFBSI-16).
Garcia SF; Rosenbloom SK; Beaumont JL; Merkel D; Von Roenn JH; Rao D; Cella D
Value Health; 2012 Jan; 15(1):183-90. PubMed ID: 22264987
[TBL] [Abstract][Full Text] [Related]
4. A brief symptom index for advanced lung cancer.
Yount S; Beaumont J; Rosenbloom S; Cella D; Patel J; Hensing T; Jacobsen PB; Syrjala K; Abernethy AP
Clin Lung Cancer; 2012 Jan; 13(1):14-23. PubMed ID: 21729652
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a symptom index for advanced hepatobiliary and pancreatic cancers: the National Comprehensive Cancer Network Functional Assessment of Cancer Therapy (NCCN-FACT) Hepatobiliary-Pancreatic Symptom Index (NFHSI).
Butt Z; Parikh ND; Beaumont JL; Rosenbloom SK; Syrjala KL; Abernethy AP; Benson AB; Cella D
Cancer; 2012 Dec; 118(23):5997-6004. PubMed ID: 22605658
[TBL] [Abstract][Full Text] [Related]
6. Development and initial validation of the NCCN/FACT symptom index for advanced kidney cancer.
Rothrock NE; Jensen SE; Beaumont JL; Abernethy AP; Jacobsen PB; Syrjala K; Cella D
Value Health; 2013; 16(5):789-96. PubMed ID: 23947972
[TBL] [Abstract][Full Text] [Related]
7. Understanding the patient experience and treatment benefits in patients with non-small-cell lung cancer with brain metastasis.
Cella D; Wen PY; Ervin C; Vallow S; Gilloteau I; DeMuro C; Mordin M; Chassot Agostinho A; Dine J
Cancer Med; 2023 Jun; 12(12):13637-13648. PubMed ID: 37306665
[TBL] [Abstract][Full Text] [Related]
8. Brief assessment of priority symptoms in hormone refractory prostate cancer: the FACT Advanced Prostate Symptom Index (FAPSI).
Yount S; Cella D; Banik D; Ashraf T; Shevrin D
Health Qual Life Outcomes; 2003 Nov; 1():69. PubMed ID: 14633279
[TBL] [Abstract][Full Text] [Related]
9. Measuring priority symptoms in advanced bladder cancer: development and initial validation of a brief symptom index.
Jensen SE; Beaumont JL; Jacobsen PB; Abernethy A; Syrjala KL; Cella D
J Support Oncol; 2013 Jun; 11(2):86-93. PubMed ID: 23089235
[TBL] [Abstract][Full Text] [Related]
10. A new index of priority symptoms in advanced ovarian cancer.
Jensen SE; Rosenbloom SK; Beaumont JL; Abernethy A; Jacobsen PB; Syrjala K; Cella D
Gynecol Oncol; 2011 Feb; 120(2):214-9. PubMed ID: 21075440
[TBL] [Abstract][Full Text] [Related]
11. Validation of the 7-item Functional Assessment of Cancer Therapy-General (FACT-G7) as a short measure of quality of life in patients with advanced cancer.
Mah K; Swami N; Le LW; Chow R; Hannon BL; Rodin G; Zimmermann C
Cancer; 2020 Aug; 126(16):3750-3757. PubMed ID: 32459377
[TBL] [Abstract][Full Text] [Related]
12. A preliminary study of a health related quality of life assessment of priority symptoms in advanced lymphoma: the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy - Lymphoma Symptom Index.
Hlubocky FJ; Webster K; Beaumont J; Cashy J; Paul D; Abernethy A; Syrjala KL; Von Roenn J; Cella D
Leuk Lymphoma; 2013 Sep; 54(9):1942-6. PubMed ID: 23320888
[TBL] [Abstract][Full Text] [Related]
13. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system.
Yellen SB; Cella DF; Webster K; Blendowski C; Kaplan E
J Pain Symptom Manage; 1997 Feb; 13(2):63-74. PubMed ID: 9095563
[TBL] [Abstract][Full Text] [Related]
14. Development of an 18-Item Measure of Symptom Burden in Patients With Glaucoma From the Collaborative Initial Glaucoma Treatment Study's Symptom and Health Problem Checklist.
Musch DC; Tarver ME; Goren MJ; Janz NK
JAMA Ophthalmol; 2017 Dec; 135(12):1345-1351. PubMed ID: 29098286
[TBL] [Abstract][Full Text] [Related]
15. Development of the Functional Assessment of Cancer Therapy-Carcinoid Syndrome Symptom Index.
Shaunfield S; Webster KA; Kaiser K; Greene GJ; Yount SE; Lacson L; Benson AB; Halperin DM; Yao JC; Singh S; Feuilly M; Marteau F; Cella D
Neuroendocrinology; 2021; 111(9):850-862. PubMed ID: 32911478
[TBL] [Abstract][Full Text] [Related]
16. Reliability and validity of the SF-36 Health Survey Questionnaire in patients with brain tumors: a cross-sectional study.
Bunevicius A
Health Qual Life Outcomes; 2017 May; 15(1):92. PubMed ID: 28472964
[TBL] [Abstract][Full Text] [Related]
17. Reliability and validity of the M. D. Anderson Symptom Inventory-Spine Tumor Module.
Armstrong TS; Gning I; Mendoza TR; Vera-Bolanos E; Gilbert MR; Rhines LD; Weinberg JS; Sanchez-Williams G; Levin V; Burton AW; Cleeland C
J Neurosurg Spine; 2010 Apr; 12(4):421-30. PubMed ID: 20367379
[TBL] [Abstract][Full Text] [Related]
18. The FACT-G7: a rapid version of the functional assessment of cancer therapy-general (FACT-G) for monitoring symptoms and concerns in oncology practice and research.
Yanez B; Pearman T; Lis CG; Beaumont JL; Cella D
Ann Oncol; 2013 Apr; 24(4):1073-8. PubMed ID: 23136235
[TBL] [Abstract][Full Text] [Related]
19. The Hand-Foot Skin Reaction and Quality of Life Questionnaire: An Assessment Tool for Oncology.
Anderson RT; Keating KN; Doll HA; Camacho F
Oncologist; 2015 Jul; 20(7):831-8. PubMed ID: 26084809
[TBL] [Abstract][Full Text] [Related]
20. Psychometric properties of self-report concussion scales and checklists.
McLeod TC; Leach C
J Athl Train; 2012; 47(2):221-3. PubMed ID: 22488289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
